3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lymphoma
2
Leukemia, Hairy Cell
2
Burkitt Lymphoma
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mesothelioma
1
Mastocytosis, Systemic
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Carcinoma in Situ
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Rituximab
63
Cyclophosphamide
57
fludarabine phosphate
40
fludarabine
37
ibrutinib
28
Lenalidomide
26
Bendamustine Hydrochloride
26
Filgrastim
20
venetoclax
19
obinutuzumab
17
Bortezomib
17
Peripheral Blood Stem Cell Transplantation
15
Etoposide
12
Biopsy
12
Tacrolimus
11
Specimen Handling
11
Melphalan
11
Interleukin-2
10
tanespimycin
9
Radiotherapy
9
Cytarabine
9
aldesleukin
8
Whole-Body Irradiation
8
Magnetic Resonance Spectroscopy
8
idelalisib
7
Vorinostat
7
Paclitaxel
7
Mycophenolic Acid
7
Ipilimumab
7
Cyclosporine
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Leukemia, Lymphocytic, Chronic, B-Cell
×
Diphenhydramine
×
Clear all
NCT00840853
2025-07-09
MULTIPRAT
Baylor College of Medicine
Phase 1
Active not recruiting
68 enrolled